Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth

Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now. On January 9, Mizuho analyst Ann Hynes raised the firm’s price target on Elevance Health to 413from413 from 400 and maintained an Outperform rating on the shares. As part of its Q4 2025 preview, Mizuho broadly revised price targets across the healthcare facilities and managed care sectors. The firm’s latest physician survey revealed a sequential slowdown in healthcare utilization growth. This deceleration suggests that the rece ...

Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth - Reportify